BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang Z, Sferra TJ, Eroglu Y. T cell co-stimulatory molecules: a co-conspirator in the pathogenesis of eosinophilic esophagitis? Dig Dis Sci 2013;58:1497-506. [PMID: 23456499 DOI: 10.1007/s10620-013-2599-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Lingblom C, Bergquist H, Johnsson M, Sundström P, Quiding-Järbrink M, Bove M, Wennerås C. Topical corticosteroids do not revert the activated phenotype of eosinophils in eosinophilic esophagitis but decrease surface levels of CD18 resulting in diminished adherence to ICAM-1, ICAM-2, and endothelial cells. Inflammation 2014;37:1932-44. [PMID: 24870064 DOI: 10.1007/s10753-014-9926-x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
2 Runge TM, Dellon ES. Do We Know What Causes Eosinophilic Esophagitis? A Mechanistic Update. Curr Gastroenterol Rep 2015;17:33. [PMID: 26205715 DOI: 10.1007/s11894-015-0458-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
3 Chen JW. Management of Eosinophilic Esophagitis: Dietary and Nondietary Approaches. Nutr Clin Pract 2020;35:835-47. [PMID: 32822071 DOI: 10.1002/ncp.10571] [Reference Citation Analysis]
4 Kern E, Hirano I. Emerging drugs for eosinophilic esophagitis. Expert Opinion on Emerging Drugs 2013;18:353-64. [DOI: 10.1517/14728214.2013.829039] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
5 Bertolini M, Zilio F, Rossi A, Kleditzsch P, Emelianov VE, Gilhar A, Keren A, Meyer KC, Wang E, Funk W, McElwee K, Paus R. Abnormal interactions between perifollicular mast cells and CD8+ T-cells may contribute to the pathogenesis of alopecia areata. PLoS One 2014;9:e94260. [PMID: 24832234 DOI: 10.1371/journal.pone.0094260] [Cited by in Crossref: 72] [Cited by in F6Publishing: 67] [Article Influence: 9.0] [Reference Citation Analysis]
6 Ware CF, Croft M, Neil GA. Realigning the LIGHT signaling network to control dysregulated inflammation. J Exp Med 2022;219:e20220236. [PMID: 35604387 DOI: 10.1084/jem.20220236] [Reference Citation Analysis]
7 Dellon ES. The pathogenesis of eosinophilic esophagitis: beyond the eosinophil. Dig Dis Sci 2013;58:1445-8. [PMID: 23625288 DOI: 10.1007/s10620-013-2679-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
8 Manresa MC, Chiang AWT, Kurten RC, Dohil R, Brickner H, Dohil L, Herro R, Akuthota P, Lewis NE, Croft M, Aceves SS. Increased Production of LIGHT by T Cells in Eosinophilic Esophagitis Promotes Differentiation of Esophageal Fibroblasts Toward an Inflammatory Phenotype. Gastroenterology 2020;159:1778-1792.e13. [PMID: 32712105 DOI: 10.1053/j.gastro.2020.07.035] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]